Srisindu Vellanki, M.D.

Assistant Professor

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Medical School: Saint Louis University School of Medicine (2015)
Residency: Stanford Healthcare/Lucile Packard Children's Hospital (2018), Pediatrics
Chief Resident: Stanford Healthcare/Lucile Packard Children's Hospital (2019), Pediatrics
Fellowship: Children's Hospital of Philadelphia (2022), Pediatric Gastroenterology

Publications

Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience: Ledder O, Dolinger M, Dubinsky MC, Stein R, Vellanki S, Buckuk R, Fatima A, Suskind DL, Scarlett J, Röser D, Shouval DS, Meyer G, Rios ZM, Pujol-Muncunill G, Lozano A, Kolho KL, Rohani P, Hussey S, De Mejj T, Ayers T, Navas-López VM, Turner D, Tzivinikos C Inflammatory bowel diseases 2025 Feb 31 425-431
Live Video MBSR is a Feasible and Acceptable Adjunctive Therapy for Youth With Inflammatory Bowel Disease: Vellanki S, Holbein C, Boateng A, Pressman N, Kirsch J, Sibinga E, Mascarenhas M, Albenberg L Global Advances in Health and Medicine 2025 Jan 14
Growth hormone use in pediatric inflammatory bowel disease: Crisci M, Vellanki S, Baldassano RN, Chen Y, Liu YL, Stein R, Hatch-Stein J Journal of Pediatric Endocrinology and Metabolism 2023 Nov 36 1012-1017
Integrative health therapies for pediatric IBD: Vellanki S, Panganiban J, Erlichman J, Mascarenhas M 2023 Feb 539-554
Righting the Autonomy-Supervision Pendulum: Understanding the Impact of Independent Rounds on Medical Students, Residents, and Faculty: Moriarty JA, Vellanki S, Trope LA, Hilgenberg SL, Blankenburg RL Academic Medicine 2020 Nov 95 S28-S36
Yoga as adjunct therapy for adolescents with inflammatory bowel disease: A pilot clinical trial: Arruda JM, Bogetz AL, Vellanki S, Wren A, Yeh AM Complementary Therapies in Medicine 2018 Dec 41 99-104